Peter A. Kiener
SVP, Research, MEDIMMUNE INC /DE.
Companies
- LAVA Therapeutics NVBoard member Jan 2, 2025 to now1
- Cue Biopharma, Inc.Board member Dec 27, 2017 to now2
- PALVELLA THERAPEUTICS, INC.Board member Sep 14, 2018 to Jun 23, 20233
- Sucampo PharmaceuticalsChief Scientific Officer Mar 13, 2015 to Feb 13, 20184
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Cue Biopharma, Inc. CUE357 shares5$6.0K at $16.71Mar 23, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 23, 2023Sold 9,325 shares at $3.28 of Cue Biopharma, Inc.5
- Mar 23, 2023Exercised options 9,682 shares at $2.86 of Cue Biopharma, Inc.5
- Nov 16, 2021Sold 1,361 shares at $18.02 of Cue Biopharma, Inc.6
- Nov 16, 2021Exercised options 1,361 shares at $2.86 of Cue Biopharma, Inc.6
- Nov 15, 2021Sold 18,815 shares at $17.92 of Cue Biopharma, Inc.6
- Nov 15, 2021Exercised options 18,815 shares at $2.86 of Cue Biopharma, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARLAVA Therapeutics NV, Board member
- 2SEC EDGARCue Biopharma, Inc., Board member
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Nov 17, 2021